Leap Therapeutics Employee Directory

Leap Therapeutics corporate office is located in 47 Thorndike St Ste B1-1, Cambridge, Massachusetts, 02141, United States and has 51-200 employees.

Employees by Department

Departments

Number of employees

C-Suite

3

Engineering & Technical

2

Operations

1

Finance

1

Leap Therapeutics CEO

MS
United States flag for contact location.
Mitchell ShirvanChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Leap Therapeutics

Leap Therapeutics Global Presence

globalPresence illustration
North America1-10
Asia1-10

Index of contact profiles from Leap Therapeutics

Hundreds of professionals searching for Leap Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Leap Therapeutics

Explore people who held key positions, contributed to Leap Therapeutics's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding Leap Therapeutics Employees

How many employees does Leap Therapeutics have?
Leap Therapeutics has 51-200 employees
Who is the CEO of Leap Therapeutics?
Leap Therapeutics’s CEO is Mitchell Shirvan
Who are Leap Therapeutics key employees?
Some of Leap Therapeutics key employees are Cassandra Choe-Juliak, Nicola Majchrzak
Where is Leap Therapeutics located?
Leap Therapeutics’s headquarters are located at 47 Thorndike St Ste B1-1, Cambridge, Massachusetts, 02141, United States
How do I contact Leap Therapeutics?
Leap Therapeutics Contact Info: Phone number: (617) 714-0360 Website: www.leaptx.com
What does Leap Therapeutics do?

Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leaps most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-301, is a humanized monoc... lonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. Leap also has preclinical antibody programs targeting Claudin18.2/CD137 and GDF15.Read More

Is Leap Therapeutics a public company?
Yes, Leap Therapeutics is a public company and is traded under the symbol LPTX
See more information about Leap Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.